{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T20:35:42Z","timestamp":1784234142423,"version":"3.55.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"DOI":"10.1186\/s12969-026-01215-6","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T09:27:09Z","timestamp":1776158829000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Expert collaborative evidence-based consensus for childhood lupus nephritis diagnosis and treatment: unifying clinical approach in Saudi Arabia"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8091-3226","authenticated-orcid":false,"given":"Abdulaziz","family":"AlMutairi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulaziz","family":"Bahassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Sandokji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emtenan","family":"Basahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sulaiman M.","family":"Al-Mayouf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Alhasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Alsaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Majeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jameela A.","family":"Kari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wafaa","family":"AlSuwairi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulkarim","family":"AlAnazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullatif","family":"Alenazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naif","family":"Abdulmajeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajdi","family":"AlMutairi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiam","family":"AlMaiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Olfat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohmmad","family":"AlTuwigri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muneera","family":"Alabdulqader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdurhman","family":"Asiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa","family":"Hakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khairiyah","family":"AlSufyani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khamisa","family":"AlMokali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hosam","family":"AlThagafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Al\u00a0Alsheikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emad","family":"Anam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samah","family":"Zahran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan","family":"Al\u00a0Rayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghada","family":"Ankawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Nashawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,14]]},"reference":[{"issue":"6","key":"1215_CR1","doi-asserted-by":"publisher","first-page":"612","DOI":"10.5144\/0256-4947.1997.612","volume":"17","author":"S Bahabri","year":"1997","unstructured":"Bahabri S, Sabban EA, Al Rashed A, Al-Mayouf S, Al Mazyed A, Abdulrazik A, et al. Juvenile systemic lupus erythematosus in 60 Saudi children. Ann Saudi Med. 1997;17(6):612\u20135.","journal-title":"Ann Saudi Med"},{"issue":"1","key":"1215_CR2","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00296-009-1210-2","volume":"31","author":"MA Muzaffer","year":"2011","unstructured":"Muzaffer MA, Al-Mayouf SM. Clinical and laboratory variables of childhood systemic lupus erythematosus in western province of Saudi Arabia. Rheumatol Int. 2011;31(1):23\u20136.","journal-title":"Rheumatol Int"},{"issue":"5","key":"1215_CR3","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.4103\/1319-2442.215142","volume":"28","author":"SM Al-Mayouf","year":"2017","unstructured":"Al-Mayouf SM, AlAmeer A, Alfattani A, Alsonbul A. Outcome of childhood lupus nephritis in Saudi children. Saudi J Kidney Dis Transpl. 2017;28(5):1015\u201320.","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"6","key":"1215_CR4","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1136\/annrheumdis-2020-216924","volume":"79","author":"A Fanouriakis","year":"2020","unstructured":"Fanouriakis A, Kostopoulou M, Cheema K, Anders HJ, Aringer M, Bajema I, et al. 2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR\/ERA-EDTA) recommendations for the management of lupus nephritis. Ann Rheum Dis. 2020;79(6):713\u201323.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1215_CR5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.kint.2023.09.001","volume":"105","author":"BH Rovin","year":"2024","unstructured":"Rovin BH, Ayoub IM, Chan TM, Liu ZH, Mej\u00eda-Vilet JM, Balk EM, et al. Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Management of Lupus Nephritis. Kidney Int. 2024;105(1):31\u20134.","journal-title":"Kidney Int"},{"issue":"12","key":"1215_CR6","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1136\/annrheumdis-2017-211898","volume":"76","author":"N Groot","year":"2017","unstructured":"Groot N, de Graeff N, Marks SD, Brogan P, Avcin T, Bader-Meunier B, et al. European evidence-based recommendations for the diagnosis and treatment of childhood-onset lupus nephritis: the SHARE initiative. Ann Rheum Dis. 2017;76(12):1965\u201373.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"1215_CR7","first-page":"576","volume":"34","author":"A AlMutairi","year":"2023","unstructured":"AlMutairi A, Al-Mayouf SM, Kari J, Basahl E, Nashawi M. Practice Patterns and Approach to Childhood Lupus Nephritis in Saudi Arabia. Saudi J Kidney Dis Transpl. 2023;34(6):576\u201391.","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"9","key":"1215_CR8","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1136\/ard.2004.023697","volume":"63","author":"M Dougados","year":"2004","unstructured":"Dougados M, Betteridge N, Burmester GR, Euller-Ziegler L, Guillemin F, Hirvonen J, et al. EULAR standardised operating procedures for the elaboration, evaluation, dissemination, and implementation of recommendations endorsed by the EULAR standing committees. Ann Rheum Dis. 2004;63(9):1172\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"1215_CR9","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1136\/jech.52.6.377","volume":"52","author":"SH Downs","year":"1998","unstructured":"Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health. 1998;52(6):377\u201384.","journal-title":"J Epidemiol Community Health"},{"issue":"2","key":"1215_CR10","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3129\/i08-001","volume":"43","author":"P Hooper","year":"2008","unstructured":"Hooper P, Jutai JW, Strong G, Russell-Minda E. Age-related macular degeneration and low-vision rehabilitation: a systematic review. Can J Ophthalmol. 2008;43(2):180\u20137.","journal-title":"Can J Ophthalmol"},{"key":"1215_CR11","unstructured":"Oxford centre for evidence-based medicine \u2013 levels of evidence. 2009."},{"issue":"1","key":"1215_CR12","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s42358-020-0114-4","volume":"60","author":"DF Miguel","year":"2020","unstructured":"Miguel DF, Terreri MT, Pereira RMR, Bonf\u00e1 E, Silva CAA, Corrente JE, et al. Comparison of urinary parameters, biomarkers, and outcome of childhood systemic lupus erythematosus early onset-lupus nephritis. Adv Rheumatol. 2020;60(1):10.","journal-title":"Adv Rheumatol"},{"issue":"8","key":"1215_CR13","first-page":"907","volume":"36","author":"Y Morimoto","year":"1994","unstructured":"Morimoto Y, Odaka K, Kagami S. Evaluation of laboratory parameters reflecting activity of lupus nephritis in children: indicators of severe renal lesions. Japanese J Nephrol. 1994;36(8):907\u201313.","journal-title":"Japanese J Nephrol"},{"issue":"1","key":"1215_CR14","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.advms.2021.01.004","volume":"66","author":"H Szymanik-Grzelak","year":"2021","unstructured":"Szymanik-Grzelak H, Barabasz M, Wikiera-Magott I, Banaszak B, Wieczorkiewicz-P\u0142aza A, Bienia\u015b B, et al. Retrospective analysis of clinical and pathomorphological features of lupus nephritis in children. Adv Med Sci. 2021;66(1):128\u201337.","journal-title":"Adv Med Sci"},{"issue":"4","key":"1215_CR15","first-page":"248","volume":"95","author":"AK Leung","year":"2017","unstructured":"Leung AK, Wong AH, Barg SS. Proteinuria in Children: Evaluation and Differential Diagnosis. Am Fam Physician. 2017;95(4):248\u201354.","journal-title":"Am Fam Physician"},{"issue":"2","key":"1215_CR16","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s10067-016-3491-7","volume":"36","author":"H Wakiguchi","year":"2017","unstructured":"Wakiguchi H, Takei S, Kubota T, Miyazono A, Kawano Y. Treatable renal disease in children with silent lupus nephritis detected by baseline biopsy: association with serum C3 levels. Clin Rheumatol. 2017;36(2):433\u20137.","journal-title":"Clin Rheumatol"},{"key":"1215_CR17","doi-asserted-by":"crossref","unstructured":"KDIGO. 2024 Clinical Practice Guideline for the management of lupus nephritis. Kidney Int. 2024;105(1s):S1-s69.","DOI":"10.1016\/j.kint.2023.09.002"},{"issue":"14","key":"1215_CR18","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1177\/0961203313502110","volume":"22","author":"PY Lee","year":"2013","unstructured":"Lee PY, Yeh KW, Yao TC, Lee WI, Lin YJ, Huang JL. The outcome of patients with renal involvement in pediatric-onset systemic lupus erythematosus\u2013a 20-year experience in Asia. Lupus. 2013;22(14):1534\u201340.","journal-title":"Lupus"},{"issue":"12","key":"1215_CR19","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1016\/j.ekir.2020.09.007","volume":"5","author":"A Chedid","year":"2020","unstructured":"Chedid A, Rossi GM, Peyronel F, Menez S, Atta MG, Bagnasco SM, et al. Low-Level Proteinuria in Systemic Lupus Erythematosus. Kidney Int Rep. 2020;5(12):2333\u201340.","journal-title":"Kidney Int Rep"},{"issue":"2","key":"1215_CR20","doi-asserted-by":"publisher","first-page":"154","DOI":"10.4103\/1319-2442.391894","volume":"34","author":"AS Al Arfaj","year":"2023","unstructured":"Al Arfaj AS, Khalil N. Levels of Proteinuria and Renal Pathology in Systemic Lupus Erythematosus Patients. Saudi J Kidney Dis Transpl. 2023;34(2):154\u201360.","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"8","key":"1215_CR21","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.2215\/CJN.01280122","volume":"17","author":"S Wang","year":"2022","unstructured":"Wang S, Spielman A, Ginsberg M, Petri M, Rovin BH, Buyon J, et al. Short- and Long-Term Progression of Kidney Involvement in Systemic Lupus Erythematosus Patients with Low-Grade Proteinuria. Clin J Am Soc Nephrol. 2022;17(8):1150\u20138.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"1215_CR22","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s11255-021-03021-3","volume":"54","author":"P Zhai","year":"2022","unstructured":"Zhai P, Huang Y, Yue S, Yang X, Luo J, Zhang Y, et al. Diagnostic efficacy and influence factors of urinary protein\/creatinine ratio replacing 24-h urine protein as an evaluator of proteinuria in children. Int Urol Nephrol. 2022;54(6):1409\u201316.","journal-title":"Int Urol Nephrol"},{"issue":"4","key":"1215_CR23","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.kint.2017.11.023","volume":"93","author":"IM Bajema","year":"2018","unstructured":"Bajema IM, Wilhelmus S, Alpers CE, Bruijn JA, Colvin RB, Cook HT, et al. Revision of the International Society of Nephrology\/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices. Kidney Int. 2018;93(4):789\u201396.","journal-title":"Kidney Int"},{"issue":"12","key":"1215_CR24","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.1007\/s00467-022-05625-y","volume":"37","author":"P Patel","year":"2022","unstructured":"Patel P, Guzman M, Hicks MJ, Maliakkal JG, Rheault MN, Selewski DT, et al. Correction to: Utility of the 2018 revised ISN\/RPS thresholds for glomerular crescents in childhood-onset lupus nephritis: a Pediatric Nephrology Research Consortium study. Pediatr Nephrol. 2022;37(12):3255.","journal-title":"Pediatr Nephrol"},{"issue":"5","key":"1215_CR25","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s40620-014-0157-x","volume":"28","author":"A Elmougy","year":"2015","unstructured":"Elmougy A, Sarhan A, Hammad A, El-Refaey A, Zedan M, Eid R, et al. Lupus nephritis in Egyptian children: a 16-year experience. J Nephrol. 2015;28(5):557\u201362.","journal-title":"J Nephrol"},{"issue":"2","key":"1215_CR26","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s00467-021-05164-y","volume":"37","author":"S Qiu","year":"2022","unstructured":"Qiu S, Zhang H, Yu S, Yang Q, Zhang G, Yang H, et al. Clinical manifestations, prognosis, and treat-to-target assessment of pediatric lupus nephritis. Pediatr Nephrol. 2022;37(2):367\u201376.","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"1215_CR27","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1177\/0961203320984539","volume":"30","author":"B Bagheri","year":"2021","unstructured":"Bagheri B, Owji SM, Torabinezhad S, Raeisi Shahraki H, Kamalinia A, Owji SH, et al. Electron microscopy study of 496 cases of lupus nephritis: A single-center experience. Lupus. 2021;30(4):587\u201396.","journal-title":"Lupus"},{"issue":"9","key":"1215_CR28","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.2215\/CJN.00910111","volume":"6","author":"T Pereira","year":"2011","unstructured":"Pereira T, Abitbol CL, Seeherunvong W, Katsoufis C, Chandar J, Freundlich M, et al. Three decades of progress in treating childhood-onset lupus nephritis. Clin J Am Soc Nephrol. 2011;6(9):2192\u20139.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"1215_CR29","doi-asserted-by":"publisher","first-page":"499","DOI":"10.3109\/0886022X.2011.573897","volume":"33","author":"S Taheri","year":"2011","unstructured":"Taheri S, Beiraghdar F. Lupus nephritis in Iranian children: a review of 60 patients. Ren Fail. 2011;33(5):499\u2013505.","journal-title":"Ren Fail"},{"issue":"1","key":"1215_CR30","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ekir.2022.10.014","volume":"8","author":"EY Chan","year":"2023","unstructured":"Chan EY, Yap DY, Wong WT, Wong WH, Wong SW, Lin KY, et al. Long-Term Outcomes of Children and Adolescents With Biopsy-Proven Childhood-Onset Lupus Nephritis. Kidney Int Rep. 2023;8(1):141\u201350.","journal-title":"Kidney Int Rep"},{"issue":"1","key":"1215_CR31","doi-asserted-by":"publisher","first-page":"e000123","DOI":"10.1136\/lupus-2015-000123","volume":"2","author":"F Tamirou","year":"2015","unstructured":"Tamirou F, Lauwerys BR, Dall\u2019Era M, Mackay M, Rovin B, Cervera R, et al. A proteinuria cut-off level of 0.7\u00a0g\/day after 12\u2005months of treatment best predicts long-term renal outcome in lupus nephritis: data from the MAINTAIN Nephritis Trial. Lupus Sci Med. 2015;2(1):e000123.","journal-title":"Lupus Sci Med"},{"issue":"3","key":"1215_CR32","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/s00296-011-2239-6","volume":"33","author":"M Trachana","year":"2013","unstructured":"Trachana M, Koutsonikoli A, Farmaki E, Printza N, Tzimouli V, Papachristou F. Safety and efficacy of rituximab in refractory pediatric systemic lupus erythematosus nephritis: a single-center experience of Northern Greece. Rheumatol Int. 2013;33(3):809\u201313.","journal-title":"Rheumatol Int"},{"issue":"6","key":"1215_CR33","first-page":"430","volume":"72","author":"H Tanaka","year":"2009","unstructured":"Tanaka H, Oki E, Tsuruga K, Yashiro T, Hanada I, Ito E. Management of young patients with lupus nephritis using tacrolimus administered as a single daily dose. Clin Nephrol. 2009;72(6):430\u20136.","journal-title":"Clin Nephrol"},{"issue":"1","key":"1215_CR34","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/ki.2015.318","volume":"89","author":"M Rathi","year":"2016","unstructured":"Rathi M, Goyal A, Jaryal A, Sharma A, Gupta PK, Ramachandran R, et al. Comparison of low-dose intravenous cyclophosphamide with oral mycophenolate mofetil in the treatment of lupus nephritis. Kidney Int. 2016;89(1):235\u201342.","journal-title":"Kidney Int"},{"issue":"4","key":"1215_CR35","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s00296-018-3995-3","volume":"38","author":"S Mehra","year":"2018","unstructured":"Mehra S, Usdadiya JB, Jain VK, Misra DP, Negi VS. Comparing the efficacy of low-dose vs high-dose cyclophosphamide regimen as induction therapy in the treatment of proliferative lupus nephritis: a single center study. Rheumatol Int. 2018;38(4):557\u201368.","journal-title":"Rheumatol Int"},{"issue":"2","key":"1215_CR36","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1053\/j.ajkd.2010.08.036","volume":"57","author":"W Chen","year":"2011","unstructured":"Chen W, Tang X, Liu Q, Chen W, Fu P, Liu F, et al. Short-term outcomes of induction therapy with tacrolimus versus cyclophosphamide for active lupus nephritis: A multicenter randomized clinical trial. Am J Kidney Dis. 2011;57(2):235\u201344.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"1215_CR37","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.kint.2018.08.025","volume":"95","author":"BH Rovin","year":"2019","unstructured":"Rovin BH, Solomons N, Pendergraft WF 3rd, Dooley MA, Tumlin J, Romero-Diaz J, et al. A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis. Kidney Int. 2019;95(1):219\u201331.","journal-title":"Kidney Int"},{"issue":"5","key":"1215_CR38","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1177\/0961203319836712","volume":"28","author":"E Smith","year":"2019","unstructured":"Smith E, Al-Abadi E, Armon K, Bailey K, Ciurtin C, Davidson J, et al. Outcomes following mycophenolate mofetil versus cyclophosphamide induction treatment for proliferative juvenile-onset lupus nephritis. Lupus. 2019;28(5):613\u201320.","journal-title":"Lupus"},{"issue":"1","key":"1215_CR39","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12969-018-0279-0","volume":"16","author":"JC Cooper","year":"2018","unstructured":"Cooper JC, Rouster-Stevens K, Wright TB, Hsu JJ, Klein-Gitelman MS, Ardoin SP, et al. Pilot study comparing the childhood arthritis and rheumatology research alliance consensus treatment plans for induction therapy of juvenile proliferative lupus nephritis. Pediatr Rheumatol Online J. 2018;16(1):65.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"5","key":"1215_CR40","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1007\/s11255-012-0331-9","volume":"45","author":"P Vachvanichsanong","year":"2013","unstructured":"Vachvanichsanong P, Dissaneewate P, McNeil E. Intravenous cyclophosphamide combined with steroids in pediatric onset severe lupus nephritis. Int Urol Nephrol. 2013;45(5):1301\u20138.","journal-title":"Int Urol Nephrol"},{"issue":"12","key":"1215_CR41","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1002\/acr.23215","volume":"69","author":"SY Tian","year":"2017","unstructured":"Tian SY, Silverman ED, Pullenayegum E, Brown PE, Beyene J, Feldman BM. Comparative Effectiveness of Mycophenolate Mofetil for the Treatment of Juvenile-Onset Proliferative Lupus Nephritis. Arthritis Care Res (Hoboken). 2017;69(12):1887\u201394.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"1215_CR42","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1136\/ard.2008.102533","volume":"69","author":"FA Houssiau","year":"2010","unstructured":"Houssiau FA, Vasconcelos C, D\u2019Cruz D, Sebastiani GD, de Ramon Garrido E, Danieli MG, et al. The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide. Ann Rheum Dis. 2010;69(1):61\u20134.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1215_CR43","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0022-3476(82)80203-5","volume":"101","author":"KS Barron","year":"1982","unstructured":"Barron KS, Person DA, Brewer EJ Jr., Beale MG, Robson AM. Pulse methylprednisolone therapy in diffuse proliferative lupus nephritis. J Pediatr. 1982;101(1):137\u201341.","journal-title":"J Pediatr"},{"issue":"14","key":"1215_CR44","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1177\/0961203311418269","volume":"20","author":"M Zeher","year":"2011","unstructured":"Zeher M, Doria A, Lan J, Aroca G, Jayne D, Boletis I, et al. Efficacy and safety of enteric-coated mycophenolate sodium in combination with two glucocorticoid regimens for the treatment of active lupus nephritis. Lupus. 2011;20(14):1484\u201393.","journal-title":"Lupus"},{"issue":"8","key":"1215_CR45","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.autrev.2017.05.017","volume":"16","author":"G Ruiz-Irastorza","year":"2017","unstructured":"Ruiz-Irastorza G, Ugarte A, Saint-Pastou Terrier C, Lazaro E, Iza A, Couzi L, et al. Repeated pulses of methyl-prednisolone with reduced doses of prednisone improve the outcome of class III, IV and V lupus nephritis: An observational comparative study of the Lupus-Cruces and lupus-Bordeaux cohorts. Autoimmun Rev. 2017;16(8):826\u201332.","journal-title":"Autoimmun Rev"},{"issue":"2","key":"1215_CR46","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s00467-020-04733-x","volume":"36","author":"A Godron-Dubrasquet","year":"2021","unstructured":"Godron-Dubrasquet A, Woillard JB, Decramer S, Fila M, Guigonis V, Tellier S, et al. Mycophenolic acid area under the concentration-time curve is associated with therapeutic response in childhood-onset lupus nephritis. Pediatr Nephrol. 2021;36(2):341\u20137.","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"1215_CR47","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1177\/0961203315615220","volume":"25","author":"E Aragon","year":"2016","unstructured":"Aragon E, Resontoc LP, Chan YH, Lau YW, Tan PH, Loh HL, et al. Long-term outcomes with multi-targeted immunosuppressive protocol in children with severe proliferative lupus nephritis. Lupus. 2016;25(4):399\u2013406.","journal-title":"Lupus"},{"issue":"1","key":"1215_CR48","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00467-017-3767-4","volume":"33","author":"J Hogan","year":"2018","unstructured":"Hogan J, Godron A, Baudouin V, Kwon T, Harambat J, Desch\u00eanes G, et al. Combination therapy of rituximab and mycophenolate mofetil in childhood lupus nephritis. Pediatr Nephrol. 2018;33(1):111\u20136.","journal-title":"Pediatr Nephrol"},{"issue":"12","key":"1215_CR49","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1056\/NEJMoa2001180","volume":"383","author":"R Furie","year":"2020","unstructured":"Furie R, Rovin BH, Houssiau F, Malvar A, Teng YKO, Contreras G, et al. Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis. N Engl J Med. 2020;383(12):1117\u201328.","journal-title":"N Engl J Med"},{"issue":"1","key":"1215_CR50","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00467-009-1291-x","volume":"25","author":"E Baskin","year":"2010","unstructured":"Baskin E, Ozen S, Cakar N, Bayrakci US, Demirkaya E, Bakkaloglu A. The use of low-dose cyclophosphamide followed by AZA\/MMF treatment in childhood lupus nephritis. Pediatr Nephrol. 2010;25(1):111\u20137.","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"1215_CR51","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1177\/0300060518796751","volume":"47","author":"Y Mao","year":"2019","unstructured":"Mao Y, Yin L, Huang H, Zhou Z, Chen T, Zhou W. Addition of cyclosporine\/tacrolimus for pediatric relapsed lupus nephritis during mycophenolate mofetil maintenance therapy. J Int Med Res. 2019;47(1):105\u201313.","journal-title":"J Int Med Res"},{"issue":"11","key":"1215_CR52","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1177\/0961203307081914","volume":"16","author":"H Tanaka","year":"2007","unstructured":"Tanaka H, Oki E, Tsugawa K, Nonaka K, Suzuki K, Ito E. Effective treatment of young patients with pediatric-onset, long-standing lupus nephritis with tacrolimus given as a single daily dose: an open-label pilot study. Lupus. 2007;16(11):896\u2013900.","journal-title":"Lupus"},{"issue":"10","key":"1215_CR53","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1136\/annrheumdis-2022-222435","volume":"81","author":"N Jourde-Chiche","year":"2022","unstructured":"Jourde-Chiche N, Costedoat-Chalumeau N, Baumstarck K, Loundou A, Bouillet L, Burtey S, et al. Weaning of maintenance immunosuppressive therapy in lupus nephritis (WIN-Lupus): results of a multicentre randomised controlled trial. Ann Rheum Dis. 2022;81(10):1420\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"1215_CR54","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1177\/0961203316662720","volume":"26","author":"A Boneparth","year":"2017","unstructured":"Boneparth A, Wenderfer SE, Moorthy LN, Radhakrishna SM, Sagcal-Gironella AC, von Scheven E. Clinical characteristics of children with membranous lupus nephritis: the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry. Lupus. 2017;26(3):299\u2013306.","journal-title":"Lupus"},{"issue":"2","key":"1215_CR55","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.kint.2022.04.023","volume":"102","author":"JC Chang","year":"2022","unstructured":"Chang JC, Weiss PF, Xiao R, Atkinson MA, Wenderfer SE. Use of renin angiotensin aldosterone system inhibitors in children with lupus and time to glucocorticoid discontinuation. Kidney Int. 2022;102(2):395\u2013404.","journal-title":"Kidney Int"},{"issue":"11","key":"1215_CR56","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1002\/acr.23219","volume":"69","author":"LT Hiraki","year":"2017","unstructured":"Hiraki LT, Feldman CH, Marty FM, Winkelmayer WC, Guan H, Costenbader KH. Serious Infection Rates Among Children With Systemic Lupus Erythematosus Enrolled in Medicaid. Arthritis Care Res (Hoboken). 2017;69(11):1620\u20136.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"1215_CR57","unstructured":"Lisowska KA, Ciesielska-Figlon K, Komorniczak M, Bu\u0142\u0142o-Piontecka B, D\u0119bska-\u015alizie\u0144 A, Wardowska A. Peripheral blood mononuclear cells and serum cytokines in patients with lupus nephritis after COVID-19. Int J Mol Sci. 2024;25(15)."},{"issue":"6","key":"1215_CR58","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.3899\/jrheum.130017","volume":"40","author":"J Isgro","year":"2013","unstructured":"Isgro J, Nurudeen SK, Imundo LF, Sauer MV, Douglas NC. Cyclophosphamide exposure in pediatric systemic lupus erythematosus is associated with reduced serum anti-mullerian hormone levels. J Rheumatol. 2013;40(6):1029\u201331.","journal-title":"J Rheumatol"},{"issue":"5","key":"1215_CR59","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1002\/art.39024","volume":"67","author":"HI Brunner","year":"2015","unstructured":"Brunner HI, Silva CA, Reiff A, Higgins GC, Imundo L, Williams CB, et al. Randomized, double-blind, dose-escalation trial of triptorelin for ovary protection in childhood-onset systemic lupus erythematosus. Arthritis Rheumatol. 2015;67(5):1377\u201385.","journal-title":"Arthritis Rheumatol"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12969-026-01215-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-026-01215-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-026-01215-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T08:01:42Z","timestamp":1776672102000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12969-026-01215-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1215"],"URL":"https:\/\/doi.org\/10.1186\/s12969-026-01215-6","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,14]]},"assertion":[{"value":"23 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25"}}